Safety and Effectiveness of Regorafenib in Sorafenib Treated Patients with Recurrent Hepatocellular Carcinoma after Liver Transplantation: An International Multicenter Study

被引：0

作者：

Iavarone, Massimo ^{[1
,2
,3
]}

Invernizzi, Federica ^{[1
,2
,3
]}

Czauderna, Carolin ^{[4
]}

Sanduzzi Zamparelli, Marco ^{[5
]}

Bhoori, Sherrie ^{[6
,7
]}

Amaddeo, Giuliana ^{[8
]}

Manini, Matteo ^{[9
]}

Fraile Lopez, Miguel ^{[10
]}

Anders, Margarita ^{[11
]}

Pinter, Matthias ^{[12
]}

Blanco Rodriguez, Maria Jose ^{[13
]}

Romero Cristobal, Mario ^{[14
]}

Aballay Soteras, Gabriel ^{[15
]}

Pinero, Federico ^{[16
]}

Villadsen, Gerda Elisabeth ^{[17
]}

Weinmann, Arndt ^{[18
]}

Crespo, Gonzalo ^{[19
]}

Mazzaferro, Vincenzo ^{[6
,7
]}

Regnault, Helene ^{[20
]}

De Giorgio, Massimo ^{[9
]}

Gonzalez Dieguez, Maria Luisa ^{[21
]}

Donato, Maria Francesca ^{[1
,2
,3
]}

Varela, Maria ^{[10
]}

Worns, Marcus ^{[4
]}

Lampertico, Pietro ^{[1
,2
,3
]}

Reig, Maria ^{[5
]}

机构：

[1] Univ Milan, CRC AM & A Migliavacca Ctr Liver Dis, Milan, Italy

[2] Univ Milan, Div Gastroenterol & Hepatol, Milan, Italy

[3] Fdn Irccs Ca Granda Maggiore Hosp, Milan, Italy

[4] Johannes Gutenberg Univ Mainz, Dept Med 1, Mainz, Germany

[5] Univ Barcelona, Hosp Clin, Barcelona Clin Liver Canc BCLC Grp, Liver Unit,Idibaps,Ciberehd, Barcelona, Spain

[6] Univ Milan, Liver Surg Transplantat & Gastroenterol, Milan, Italy

[7] Ist Nazl Tumori Fdn Irccs, Milan, Italy

[8] Hop Henri Mondor, Serv Hepatol, Virus Immunite Canc, Equipe 18,Inserm,U955, Creteil, France

[9] Azienda Socio Sanit Terr ASST Papa Giovanni XXIII, Dept Specialty & Transplant Med, Gastroenterol Hepatol & Transplant Unit, Bergamo, Italy

[10] Hosp Univ Cent Asturias, Liver Unit, Oviedo, Spain

[11] Hosp Aleman, Unidad Hepatol & Trasplante Hepat, Buenos Aires, DF, Argentina

[12] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria

[13] Hosp Jerez, Jerez de la Frontera, Spain

[14] Gregorio Maranon Hosp, Liver Dept, Madrid, Spain

[15] Sanat Trinidad Mitre, Buenos Aires, DF, Argentina

[16] Hosp Univ Austral, Buenos Aires, DF, Argentina

[17] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus C, Denmark

[18] Johannes Gutenberg Univ Mainz, Dept Med 1, Mainz, Germany

[19] Univ Barcelona, Hosp Clin, Liver Transplant Unit, Liver Unit,Idibaps,Ciberehd, Barcelona, Spain

[20] Hop Henri Mondor, Serv Hepatol, Virus Immunite Canc, Equipe 18,Inserm,U955, Creteil, France

[21] Hosp Univ Cent Asturias, Liver Transplant Unit, Buenos Aires, DF, Argentina

来源：

HEPATOLOGY | 2018年 / 68卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LB-17

引用

页码：1457A / 1458A

页数：2

共 50 条

[31] Liver transplantation in a patient treated by sorafenib for hepatocellular carcinoma
Borentain, P.
Gregoire, E.
Hardwigsen, J.
Garcia, S.
Durieux, O.
Le Treut, Y. -P.
Gerolami, R.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2011, 35 (03) : 234 - 236
[32] MULTICENTER RETROSPECTIVE ANALYSIS OF THE EFFICACY OF REGORAFENIB AFTER PROGRESSION ON SORAFENIB WITH HEPATOCELLULAR CARCINOMA
Lee, Min-Jin
Chang, Sung Won
Lee, Ha Seok
Kim, Sehwa
Lee, Young-Sun
Jung, Young Kul
Suh, Sang Jun
Kim, Ji Hoon
Seo, Yeon Seok
Yim, Hyung Joon
Yeon, Jong Eun
Byun, Kwan Soo
HEPATOLOGY, 2019, 70 : 239A - 240A
[33] Safety and efficacy of sorafenib followed by regorafenib or lenvatinib in patients with hepatocellular carcinoma
Terashima, Takeshi
Yamashita, Tatsuya
Takata, Noboru
Takeda, Yasuhito
Kido, Hidenori
Iida, Noriho
Kitahara, Masaaki
Shimakami, Tetsuro
Takatori, Hajime
Arai, Kuniaki
Kawaguchi, Kazunori
Kitamura, Kazuya
Yamashita, Taro
Sakai, Yoshio
Mizukoshi, Eishiro
Honda, Masao
Kaneko, Shuichi
HEPATOLOGY RESEARCH, 2021, 51 (02) : 190 - 200
[34] Complete Remission of Recurrent Hepatocellular Carcinoma after Receiving a Living Donor Liver Transplantation Treated with Sorafenib.
Ryu, Jeho
Moon, Kimyung
Chu, Chongwoo
Yang, Kwangho
LIVER TRANSPLANTATION, 2013, 19 : S154 - S154
[35] Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation
Gomez-Martin, Carlos
Bustamante, Javier
Castroagudin, Javier F.
Salcedo, Magdalena
Garralda, Elena
Testillano, Milagros
Herrero, Ignacio
Matilla, Ana
Sangro, Bruno
LIVER TRANSPLANTATION, 2012, 18 (01) : 45 - 52
[36] Efficacy and safety of regorafenib after progression on sorafenib in Korean patients with advanced hepatocellular carcinoma (HCC)
Yoo, C.
Park, J-W.
Kim, Y. J.
Kim, D. Y.
Yu, S. J.
Lim, T. S.
Ryoo, B-Y.
Lee, S. J.
Lim, H-Y.
ANNALS OF ONCOLOGY, 2018, 29
[37] Safety of Liver Resection for Hepatocellular Carcinoma After Sorafenib Therapy: A Multicenter Case-Matched Study
Barbier, Louise
Fuks, David
Pessaux, Patrick
Muscari, Fabrice
Le Treut, Yves-Patrice
Faivre, Sandrine
Belghiti, Jacques
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (11) : 3603 - 3609
[38] Safety of Liver Resection for Hepatocellular Carcinoma After Sorafenib Therapy: A Multicenter Case-Matched Study
Louise Barbier
David Fuks
Patrick Pessaux
Fabrice Muscari
Yves-Patrice Le Treut
Sandrine Faivre
Jacques Belghiti
Annals of Surgical Oncology, 2013, 20 : 3603 - 3609
[39] TOLERABILITY OF SORAFENIB IN RECURRENT HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION: A CASE-CONTROL STUDY.
Dharancy, S.
Romano, O.
Lohro, R.
Pageaux, G. P.
De Ledinghen, V.
Hurtova, M.
Vanlemmens, C.
Salame, E.
Cattan, S.
Boleslamski, E.
Mathurin, R.
Pruvot, F. R.
LIVER TRANSPLANTATION, 2008, 14 (07) : S216 - S216
[40] TOLERABILITY AND EFFICACY OF SORAFENIB IN RECURRENT HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION: A CASE-CONTROL STUDY
Dharancy, Sebastien
Romano, Olivier
Lorho, Richard
Pageaux, Georges Philippe
de Ledinghen, Victor
Hurtova, Monika
Vanlemmens, Claire
Salame, Ephrem
Wolf, Philippe
Dumortier, Jerome
Hilleret, Marie Noelle
Cattan, Stephane
Mathurin, Philippe
Pruvot, Francois Rene
HEPATOLOGY, 2008, 48 (04) : 310A - 310A

← 1 2 3 4 5 →